发明名称 |
N1/N2-lactam acetyl-CoA carboxylase inhibitors |
摘要 |
The invention provides a compound of Formula (I);
or a pharmaceutically acceptable salt thereof; wherein
G is
;
R1, R2 and R3 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal. |
申请公布号 |
US8859773(B2) |
申请公布日期 |
2014.10.14 |
申请号 |
US201113282964 |
申请日期 |
2011.10.27 |
申请人 |
Pfizer Inc. |
发明人 |
Griffith David A.;Dow Robert L.;Bagley Scott W.;Smith Aaron |
分类号 |
C07D471/20;C07D519/00;A61K31/4725 |
主分类号 |
C07D471/20 |
代理机构 |
|
代理人 |
Wasicak James T. |
主权项 |
1. A compound of structure or a pharmaceutically acceptable salt thereof. |
地址 |
New York NY US |